231 related articles for article (PubMed ID: 23404497)
1. Adenylosuccinate synthetase and adenylosuccinate lyase deficiencies trigger growth and infectivity deficits in Leishmania donovani.
Boitz JM; Strasser R; Yates PA; Jardim A; Ullman B
J Biol Chem; 2013 Mar; 288(13):8977-90. PubMed ID: 23404497
[TBL] [Abstract][Full Text] [Related]
2. Adenine aminohydrolase from Leishmania donovani: unique enzyme in parasite purine metabolism.
Boitz JM; Strasser R; Hartman CU; Jardim A; Ullman B
J Biol Chem; 2012 Mar; 287(10):7626-39. PubMed ID: 22238346
[TBL] [Abstract][Full Text] [Related]
3. Amplification of adenine phosphoribosyltransferase suppresses the conditionally lethal growth and virulence phenotype of Leishmania donovani mutants lacking both hypoxanthine-guanine and xanthine phosphoribosyltransferases.
Boitz JM; Ullman B
J Biol Chem; 2010 Jun; 285(24):18555-64. PubMed ID: 20363738
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of pyrimidine biosynthesis and salvage in Leishmania donovani.
Wilson ZN; Gilroy CA; Boitz JM; Ullman B; Yates PA
J Biol Chem; 2012 Apr; 287(16):12759-70. PubMed ID: 22367196
[TBL] [Abstract][Full Text] [Related]
5. Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host.
Boitz JM; Yates PA; Kline C; Gaur U; Wilson ME; Ullman B; Roberts SC
Infect Immun; 2009 Feb; 77(2):756-63. PubMed ID: 19064633
[TBL] [Abstract][Full Text] [Related]
6. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
7. Arg40 is critical for stability and activity of Adenylosuccinate lyase; a purine salvage enzyme from Leishmania donovani.
Mochi JA; Jani J; Tak K; Lodhi KK; Pananghat G; Pappachan A
Arch Biochem Biophys; 2024 Jul; 757():110040. PubMed ID: 38750922
[TBL] [Abstract][Full Text] [Related]
8. GMP reductase and genetic uncoupling of adenylate and guanylate metabolism in Leishmania donovani parasites.
Boitz JM; Jardim A; Ullman B
Mol Biochem Parasitol; 2016 Aug; 208(2):74-83. PubMed ID: 27343371
[TBL] [Abstract][Full Text] [Related]
9. Adenine and adenosine salvage in Leishmania donovani.
Boitz JM; Ullman B
Mol Biochem Parasitol; 2013 Aug; 190(2):51-5. PubMed ID: 23845934
[TBL] [Abstract][Full Text] [Related]
10. Purine oversecretion in cultured murine lymphoma cells deficient in adenylosuccinate synthetase: genetic model for inherited hyperuricemia and gout.
Ullman B; Wormsted MA; Cohen MB; Martin DW
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5127-31. PubMed ID: 6957854
[TBL] [Abstract][Full Text] [Related]
11. A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani.
Boitz JM; Ullman B
J Biol Chem; 2006 Jun; 281(23):16084-9. PubMed ID: 16603734
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase.
Manhas R; Tandon S; Sen SS; Tiwari N; Munde M; Madhubala R
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941647
[TBL] [Abstract][Full Text] [Related]
13. Adenylosuccinate lyase deficiency affects neurobehavior via perturbations to tyramine signaling in Caenorhabditis elegans.
Moro CA; Sony SA; Franklin LP; Dong S; Peifer MM; Wittig KE; Hanna-Rose W
PLoS Genet; 2023 Sep; 19(9):e1010974. PubMed ID: 37773959
[TBL] [Abstract][Full Text] [Related]
14. Specificity of adenylosuccinate synthetase and adenylosuccinate lyase from Leishmania donovani. Selective amination of an antiprotozoal agent.
Spector T; Jones TE; Elion GB
J Biol Chem; 1979 Sep; 254(17):8422-6. PubMed ID: 468834
[No Abstract] [Full Text] [Related]
15. Disorders of purine biosynthesis metabolism.
Dewulf JP; Marie S; Nassogne MC
Mol Genet Metab; 2022 Jul; 136(3):190-198. PubMed ID: 34998670
[TBL] [Abstract][Full Text] [Related]
16. Adenylosuccinate lyase of Schistosoma mansoni: gene structure, mRNA expression, and analysis of the predicted peptide structure of a potential chemotherapeutic target.
Foulk BW; Pappas G; Hirai Y; Hirai H; Williams DL
Int J Parasitol; 2002 Nov; 32(12):1487-95. PubMed ID: 12392914
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages.
Boitz JM; Ullman B
Mol Biochem Parasitol; 2006 Jul; 148(1):24-30. PubMed ID: 16597468
[TBL] [Abstract][Full Text] [Related]
18. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
[TBL] [Abstract][Full Text] [Related]
19. Adenylosuccinate lyase deficiency: study of physiopathologic mechanism(s).
Race V; Marie S; Kienlen-Campard P; Hermans E; Octave JN; Van den Berghe G; Vincent MF
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1227-9. PubMed ID: 15571234
[TBL] [Abstract][Full Text] [Related]
20. Misleading behavioural phenotype with adenylosuccinate lyase deficiency.
Gitiaux C; Ceballos-Picot I; Marie S; Valayannopoulos V; Rio M; Verrieres S; Benoist JF; Vincent MF; Desguerre I; Bahi-Buisson N
Eur J Hum Genet; 2009 Jan; 17(1):133-6. PubMed ID: 18830228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
